List of Ortho-McNeil Pharmaceutical patents

Patents where

Current Assignee

Name

‌

Ortho-McNeil Pharmaceutical

Name	Description	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 7842501 Ex-vivo priming for generating cytotoxic T lymphocytes specific for non-tumor antigens to treat autoimmune and allergic disease	Patent 7842501 was granted and assigned to Ortho-McNeil Pharmaceutical on November, 2010 by the United States Patent and Trademark Office.	‌ Ortho-McNeil Pharmaceutical	United States Patent and Trademark Office	7842501	November 30, 2010
‌ US Patent 8084256 Ex-vivo priming for generating cytotoxic T lymphocytes specific for non-tumor antigens to treat autoimmune and allergic disease	Patent 8084256 was granted and assigned to Ortho-McNeil Pharmaceutical on December, 2011 by the United States Patent and Trademark Office.	‌ Ortho-McNeil Pharmaceutical	United States Patent and Trademark Office	8084256	December 27, 2011
‌ US Patent 7399767 Heterocyclic benzo[c]chromene derivatives useful as modulators of the estrogen receptors	Patent 7399767 was granted and assigned to Ortho-McNeil Pharmaceutical on July, 2008 by the United States Patent and Trademark Office.	‌ Ortho-McNeil Pharmaceutical	United States Patent and Trademark Office	7399767	July 15, 2008
‌ US Patent 7375123 1,2,4-thiadiazole derivatives as melanocortin receptor modulators	Patent 7375123 was granted and assigned to Ortho-McNeil Pharmaceutical on May, 2008 by the United States Patent and Trademark Office.	‌ Ortho-McNeil Pharmaceutical	United States Patent and Trademark Office	7375123	May 20, 2008
‌ US Patent 7115395 DNAs encoding guinea pig histamine receptors of the H4 subtype	Patent 7115395 was granted and assigned to Ortho-McNeil Pharmaceutical on October, 2006 by the United States Patent and Trademark Office.	‌ Ortho-McNeil Pharmaceutical	United States Patent and Trademark Office	7115395	October 3, 2006
‌ US Patent 7867990 Steroid hormone products and methods for preparing them	Patent 7867990 was granted and assigned to Ortho-McNeil Pharmaceutical on January, 2011 by the United States Patent and Trademark Office.	‌ Ortho-McNeil Pharmaceutical	United States Patent and Trademark Office	7867990	January 11, 2011
‌ US Patent 7186803 Human vanilloid receptor VR3 protein	Patent 7186803 was granted and assigned to Ortho-McNeil Pharmaceutical on March, 2007 by the United States Patent and Trademark Office.	‌ Ortho-McNeil Pharmaceutical	United States Patent and Trademark Office	7186803	March 6, 2007
‌ US Patent 7183252 Indole peptidomimetics as thrombin receptor antagonists	Patent 7183252 was granted and assigned to Ortho-McNeil Pharmaceutical on February, 2007 by the United States Patent and Trademark Office.	‌ Ortho-McNeil Pharmaceutical	United States Patent and Trademark Office	7183252	February 27, 2007
‌ US Patent 7259146 Neuroprotective peptides	Patent 7259146 was granted and assigned to Ortho-McNeil Pharmaceutical on August, 2007 by the United States Patent and Trademark Office.	‌ Ortho-McNeil Pharmaceutical	United States Patent and Trademark Office	7259146	August 21, 2007
‌ US Patent 7179604 Methods of use of DNA encoding a human histamine receptor of the H3 subtype	Patent 7179604 was granted and assigned to Ortho-McNeil Pharmaceutical on February, 2007 by the United States Patent and Trademark Office.	‌ Ortho-McNeil Pharmaceutical	United States Patent and Trademark Office	7179604	February 20, 2007
‌ US Patent 7408036 Human voltage gated sodium channel β1A subunit and methods of use	Patent 7408036 was granted and assigned to Ortho-McNeil Pharmaceutical on August, 2008 by the United States Patent and Trademark Office.	‌ Ortho-McNeil Pharmaceutical	United States Patent and Trademark Office	7408036	August 5, 2008
‌ US Patent 7235380 CDR-grafted anti-tissue factor antibodies and methods of use thereof	Patent 7235380 was granted and assigned to Ortho-McNeil Pharmaceutical on June, 2007 by the United States Patent and Trademark Office.	‌ Ortho-McNeil Pharmaceutical	United States Patent and Trademark Office	7235380	June 26, 2007
‌ US Patent 7179818 Substituted aminoquinuclidine compounds	Patent 7179818 was granted and assigned to Ortho-McNeil Pharmaceutical on February, 2007 by the United States Patent and Trademark Office.	‌ Ortho-McNeil Pharmaceutical	United States Patent and Trademark Office	7179818	February 20, 2007
‌ US Patent 7354742 Method for generating amplified RNA	Patent 7354742 was granted and assigned to Ortho-McNeil Pharmaceutical on April, 2008 by the United States Patent and Trademark Office.	‌ Ortho-McNeil Pharmaceutical	United States Patent and Trademark Office	7354742	April 8, 2008
‌ US Patent 7157248 CDNA encoding the human α2 δ4 calcium channel subunit	Patent 7157248 was granted and assigned to Ortho-McNeil Pharmaceutical on January, 2007 by the United States Patent and Trademark Office.	‌ Ortho-McNeil Pharmaceutical	United States Patent and Trademark Office	7157248	January 2, 2007
‌ US Patent 7358261 Heteroaryl alkylamide derivatives useful as bradykinin receptor modulators	Patent 7358261 was granted and assigned to Ortho-McNeil Pharmaceutical on April, 2008 by the United States Patent and Trademark Office.	‌ Ortho-McNeil Pharmaceutical	United States Patent and Trademark Office	7358261	April 15, 2008
‌ US Patent 7575888 Method of determining chymase activity with secretory leukocyte protease inhibitor	Patent 7575888 was granted and assigned to Ortho-McNeil Pharmaceutical on August, 2009 by the United States Patent and Trademark Office.	‌ Ortho-McNeil Pharmaceutical	United States Patent and Trademark Office	7575888	August 18, 2009
‌ US Patent 7195879 Method for identifying modulators of NA	Patent 7195879 was granted and assigned to Ortho-McNeil Pharmaceutical on March, 2007 by the United States Patent and Trademark Office.	‌ Ortho-McNeil Pharmaceutical	United States Patent and Trademark Office	7195879	March 27, 2007
‌ US Patent 7125560 Pharmaceutical composition of topiramate	Patent 7125560 was granted and assigned to Ortho-McNeil Pharmaceutical on October, 2006 by the United States Patent and Trademark Office.	‌ Ortho-McNeil Pharmaceutical	United States Patent and Trademark Office	7125560	October 24, 2006
‌ US Patent 7524643 CDNA encoding the human alpha2 delta4 calcium channel subunit	Patent 7524643 was granted and assigned to Ortho-McNeil Pharmaceutical on April, 2009 by the United States Patent and Trademark Office.	‌ Ortho-McNeil Pharmaceutical	United States Patent and Trademark Office	7524643	April 28, 2009
‌ US Patent 7317031 Substituted triazole diamine derivatives as kinase inhibitors	Patent 7317031 was granted and assigned to Ortho-McNeil Pharmaceutical on January, 2008 by the United States Patent and Trademark Office.	‌ Ortho-McNeil Pharmaceutical	United States Patent and Trademark Office	7317031	January 8, 2008
‌ US Patent 7247474 Monoclonal antibody which specifically binds to but does not activate the CD8	Patent 7247474 was granted and assigned to Ortho-McNeil Pharmaceutical on July, 2007 by the United States Patent and Trademark Office.	‌ Ortho-McNeil Pharmaceutical	United States Patent and Trademark Office	7247474	July 24, 2007
‌ US Patent 7179887 Guinea pig proteinase-activated receptor 4 and its activating peptide	Patent 7179887 was granted and assigned to Ortho-McNeil Pharmaceutical on February, 2007 by the United States Patent and Trademark Office.	‌ Ortho-McNeil Pharmaceutical	United States Patent and Trademark Office	7179887	February 20, 2007
‌ US Patent 7312045 Aggrecanase-1 and -2 peptide substrates and methods	Patent 7312045 was granted and assigned to Ortho-McNeil Pharmaceutical on December, 2007 by the United States Patent and Trademark Office.	‌ Ortho-McNeil Pharmaceutical	United States Patent and Trademark Office	7312045	December 25, 2007
‌ US Patent 8106236 Triaryl compounds and derivates thereof	Patent 8106236 was granted and assigned to Ortho-McNeil Pharmaceutical on January, 2012 by the United States Patent and Trademark Office.	‌ Ortho-McNeil Pharmaceutical	United States Patent and Trademark Office	8106236	January 31, 2012

Results per page:

93 results

0 selected

93 results

0 selected